他克莫司市场规模/份额/前景/机会（2022-2030）：按产品类型/用途/最终用户/地区

预计主要公司增加产品发布将在预测期内推动全球他克莫司市场的增长。领先公司也专注于无机增长战略，例如他克莫司产品的分销，预计这也将在预测期内推动市场增长。

在本报告中，我们调查了全球他克莫司市场，定义和概述了市场，分析了对市场增长、法律法规/赎回环境、市场规模转变/预测、各个类别/地区的各种影响因素/它总结了细分市场主要国家、竞争环境、主要公司概况等。

目录

第 1 章调查目标/先决条件

第二章市场概述

第三章市场动态/监管/趋势分析

• 市场动态
  • 促进因素
  • 抑制器
  • 市场机会
• 影响分析
• 市场趋势
• 流行病学
• 监管场景
• PEST 分析
• 赎回分析
• 价格分析
• 新产品的批准/发布
• 他克莫司替代品

第 4 章全球他克莫司市场：COVID-19 的影响

• 经济影响
• COVID-19：流行病学
• 供需分析

第 5 章全球他克莫司市场：按产品类型

• 概览
• 他克莫司胶囊/片剂
• 他克莫司软膏
• 他克莫司注射液
• 他克莫司颗粒

第 6 章全球他克莫司市场：按用途

• 概览
• 免疫抑制
• 皮炎
• 其他

第 7 章全球他克莫司市场：按最终用户

• 概览
• 器官移植中心
• 医院
• 诊所
• 其他

第 8 章全球他克莫司市场：按地区

• 北美
• 拉丁美洲
• 欧洲
• 亚太地区
• 中东
• 非洲

第9章竞争态势

• Novartis AG
• Mylan N.V.
• Astellas Pharma Inc.
• Dr. Reddy's Laboratories Ltd.
• Pfizer Inc.
• Abbott
• Senju Pharmaceutical Co. Ltd.
• Glenmark Pharmaceuticals Ltd.
• Lupin Limited
• Vibcare Pharma Pvt. Ltd.

第10章 章节

Tacrolimus is a calcineurin inhibitor and potent immunosuppressive drug that is primarily used to prevent cellular rejection following organ transplantation. It is also used topically to treat severe atopic dermatitis, severe refractory uveitis following bone marrow transplants, and the skin disorder vitiligo. Tacrolimus is available in capsule, granules for oral suspension (to be combined with liquid), extended-release (long acting) capsule, and extended-release tablet for oral administration. Tacrolimus immediate-release formulations, in combination with other immunosuppressants, are approved for the prevention of organ rejection in adult and pediatric patients receiving allogeneic liver, kidney, heart, or lung transplants. Tacrolimus extended-release formulations are approved for the prevention of organ rejection in adult and pediatric patients having kidney transplants when combined with other immunosuppressants, and may be used in patients who have been converted from immediate-release formulations.

Market Dynamics

The increasing product launch by the key players in the market is expected to drive the market growth over the forecast period. For instance, in June 2020, Sandoz, a Novartis division and a global leader in generic pharmaceuticals and biosimilars, announced the launch of once-daily generic tacrolimus capsules known as Dailiport in Germany, the U.K., The Netherlands, Finland, Sweden, Estonia, Latvia, and Slovakia, and as Conferoport in Italy and Spain.

Moreover, key companies in the market are focusing on inorganic growth strategies such as distribution of tacrolimus products, which is expected to drive the market growth over the forecast period. For instance, in January 2022, Mayne Pharma Group Limited, an Australia-based specialty pharmaceutical company announced that it had begun distribution of tacrolimus ointment, 0.1% in the U.S. Tacrolimus ointment is a generic version of PROTOPIC, indicated for the treatment of Atopic dermatitis.

Key features of the study:

• This report provides an in-depth analysis of the global tacrolimus market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global tacrolimus market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Novartis AG, Mylan N.V., Astellas Pharma Inc., Dr. Reddy's Laboratories Ltd., Pfizer Inc., Abbott, Senju Pharmaceutical Co. Ltd., Glenmark Pharmaceuticals Ltd., Lupin Limited, and Vibcare Pharma Pvt. Ltd.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global tacrolimus market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts1
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global tacrolimus market

Detailed Segmentation:

• Global Tacrolimus Market, By Product Type:
  • Tacrolimus Capsules and Tablets
  • Tacrolimus Ointment
  • Tacrolimus Injection
  • Tacrolimus Granules
• Global Tacrolimus Market, By Application:
  • Immunosuppression
  • Dermatitis
  • Others
• Global Tacrolimus Market, By End User:
  • Organ Transplant Centers
  • Hospitals
  • Clinics
  • Others
• Global Tacrolimus Market, By Region:
  • North America
    • By Country
    • U.S.
    • Canada
  • Latin America
    • By Country
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • By Country
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • By Country
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • By Country
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • By Region/Country
    • South Africa
    • Central Africa
    • North Africa
• Company Profiles
  • Novartis AG
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Mylan N.V.
  • Astellas Pharma Inc.
  • Reddy's Laboratories Ltd.
  • Pfizer Inc.
  • Abbott
  • Senju Pharmaceutical Co. Ltd.
  • Glenmark Pharmaceuticals Ltd.
  • Lupin Limited
  • Vibcare Pharma Pvt. Ltd.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product Type
  • Market Snapshot, By Application
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Market Trends
• Epidemiology
• Regulatory Scenario
• PEST Analysis
• Reimbursement Analysis
• Pricing Analysis
• New Product Approval/Launch
• Substitutes/Alternatives of Tacrolimus

4. Global Tacrolimus Market - Impact of Coronavirus (Covid-19) Pandemic

• Economic Impact
• COVID-19 Epidemiology
• Demand and Supply Analysis

5. Global Tacrolimus Market, By Product Type, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018 - 2030
  • Segment Trends
• Tacrolimus Capsules and Tablets
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Tacrolimus Ointment
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Tacrolimus Injection
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Tacrolimus Granules
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Tacrolimus Market, By Application, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018 - 2030
  • Segment Trends
• Immunosuppression
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Dermatitis
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Tacrolimus Market, By End User, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018 - 2030
  • Segment Trends
• Organ Transplant Centers
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Hospitals
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Clinics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Tacrolimus Market, By Region, 2017 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, By Region, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, For Regions, 2018-2030
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • U.S.
  • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • UK
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • GCC
  • Israel
  • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

• Novartis AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Mylan N.V.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Astellas Pharma Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Dr. Reddy's Laboratories Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Pfizer Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Abbott
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Senju Pharmaceutical Co. Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Glenmark Pharmaceuticals Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Lupin Limited
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Vibcare Pharma Pvt. Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

10. Section

• Research Methodology
• About Us